Insilico Medicine and Hygtia Therapeutics Partner...
Category : Clinical Trial Update 21 January 2026Insilico Medicine and Hygtia Therapeutics have entered an exclusive global license and co-developmen...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Insilico Medicine and Hygtia Therapeutics have entered an exclusive global license and co-developmen...
A new U.S. consumer health survey by Verb Biotics, covering 2,000 adults, found that 73% experience...
CannaLean Biotechs Ltd., a clinical-stage biotechnology company, announced the successful completion...
Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, ann...
Brenig Therapeutics has initiated a first-in-human (FIH) Phase 1 study for BT-409, its brain-selecti...